NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma

There are few prognostic biomarkers and targeted therapeutics currently in use for the clinical management of oral squamous cell carcinoma (OSCC) and patient outcomes remain poor in this disease. A majority of mutations in OSCC are loss-of-function events in tumour suppressor genes that are refracto...

Descripción completa

Detalles Bibliográficos
Autores principales: Arora, Rahul, Haynes, Logan, Kumar, Mehul, McNeil, Reid, Ashkani, Jahanshah, Nakoneshny, Steven C., Matthews, T. Wayne, Chandarana, Shamir, Hart, Robert D., Jones, Steven J. M., Dort, Joseph C., Itani, Doha, Chanda, Ayan, Bose, Pinaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191846/
https://www.ncbi.nlm.nih.gov/pubmed/36635327
http://dx.doi.org/10.1038/s41417-022-00578-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191846/
https://www.ncbi.nlm.nih.gov/pubmed/36635327
http://dx.doi.org/10.1038/s41417-022-00578-8

Ejemplares similares